KORU Medical Systems — Third Quarter 2026 Earnings Summary

KORU Medical Systems reported third-quarter 2026 net revenues of $11.6 million, an 11% increase from the prior year, driven by a 31.6% growth in domestic core sales. The company achieved its second consecutive quarter of positive net income, recording $0.2 million in profit and $1.3 million in adjusted EBITDA. Gross margin improved to 65.2% due to lower manufacturing costs and favorable customer mix, while total operating expenses rose slightly to $7.4 million. Consequently, the company revised its full-year 2026 revenue guidance upward to a range of $48.0 to $48.5 million and reiterated its expectation for positive adjusted EBITDA for the year.